Clinical Trials

Showing trials with last updates posted in 2013.

NCT00042796 | TERMINATED | PHASE1
21 participants

Decitabine in Treating Children With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2013-01-23
Start Date:
2002-12-31
Completion:
2005-10-31
Conditions
  • Childhood Acute Myeloblastic Leukemia With Maturation (M2)
  • Childhood Acute Promyelocytic Leukemia (M3)
  • Recurrent Childhood Acute Lymphoblastic Leukemia
  • Recurrent Childhood Acute Myeloid Leukemia
  • Secondary Acute Myeloid Leukemia
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT00006473 | COMPLETED | PHASE2
72 participants

Oxaliplatin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2013-01-23
Start Date:
2000-09-30
Completion:
2006-02-28
Conditions
  • Angioimmunoblastic T-cell Lymphoma
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • Nodal Marginal Zone B-cell Lymphoma
  • Recurrent Adult Burkitt Lymphoma
  • Recurrent Adult Diffuse Large Cell Lymphoma
  • Recurrent Adult Diffuse Mixed Cell Lymphoma
  • Recurrent Adult Diffuse Small Cleaved Cell Lymphoma
  • Recurrent Adult Immunoblastic Large Cell Lymphoma
  • Recurrent Adult Lymphoblastic Lymphoma
  • Recurrent Adult T-cell Leukemia/Lymphoma
  • Recurrent Grade 1 Follicular Lymphoma
  • Recurrent Grade 2 Follicular Lymphoma
  • Recurrent Grade 3 Follicular Lymphoma
  • Recurrent Mantle Cell Lymphoma
  • Recurrent Marginal Zone Lymphoma
  • Recurrent Small Lymphocytic Lymphoma
  • Waldenström Macroglobulinemia
Interventions
  • DRUG
No Results Yet
NCT00006213 | COMPLETED | PHASE1
30 participants

BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2013-01-23
Start Date:
2000-04-30
Completion:
2002-10-31
Conditions
  • Adult Acute Promyelocytic Leukemia (M3)
  • Blastic Phase Chronic Myelogenous Leukemia
  • Childhood Myelodysplastic Syndromes
  • Previously Treated Myelodysplastic Syndromes
  • Recurrent Adult Acute Lymphoblastic Leukemia
  • Recurrent Adult Acute Myeloid Leukemia
  • Recurrent Childhood Acute Lymphoblastic Leukemia
  • Recurrent Childhood Acute Myeloid Leukemia
  • Refractory Anemia With Excess Blasts
  • Refractory Anemia With Excess Blasts in Transformation
  • Relapsing Chronic Myelogenous Leukemia
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT00005973 | COMPLETED | PHASE1
36 participants

BMS-214662 in Treating Patients With Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2013-01-23
Start Date:
2000-04-30
Completion:
2004-07-31
Conditions
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Unspecified Childhood Solid Tumor, Protocol Specific
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT00005950 | TERMINATED | PHASE2
111 participants

506U78 in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or T-cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2013-01-23
Start Date:
2000-04-30
Completion:
2004-10-31
Conditions
  • Angioimmunoblastic T-cell Lymphoma
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • Nodal Marginal Zone B-cell Lymphoma
  • Recurrent Adult T-cell Leukemia/Lymphoma
  • Recurrent Grade 1 Follicular Lymphoma
  • Recurrent Grade 2 Follicular Lymphoma
  • Recurrent Marginal Zone Lymphoma
  • Recurrent Small Lymphocytic Lymphoma
  • Splenic Marginal Zone Lymphoma
  • Waldenström Macroglobulinemia
Interventions
  • DRUG
No Results Yet
NCT00005942 | COMPLETED | PHASE1/PHASE2
37 participants

Liposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial Therapy

Study Type:
INTERVENTIONAL
Last Updated:
2013-01-23
Start Date:
2000-03-31
Completion:
2000-12-31
Conditions
  • Chronic Myelomonocytic Leukemia
  • Previously Treated Myelodysplastic Syndromes
  • Recurrent Adult Acute Myeloid Leukemia
  • Refractory Anemia With Excess Blasts
  • Refractory Anemia With Excess Blasts in Transformation
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT00005838 | COMPLETED | PHASE3
756 participants

Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery

Study Type:
INTERVENTIONAL
Last Updated:
2013-01-23
Start Date:
2000-03-31
Completion:
2007-02-28
Conditions
  • Adenocarcinoma of the Lung
  • Adenosquamous Cell Lung Cancer
  • Large Cell Lung Cancer
  • Squamous Cell Lung Cancer
  • Stage IIIA Non-small Cell Lung Cancer
  • Stage IIIB Non-small Cell Lung Cancer
Interventions
  • DRUG
  • OTHER
  • RADIATION
No Results Yet
NCT00005818 | COMPLETED | PHASE1/PHASE2
68 participants

SU5416 and Irinotecan in Treating Patients With Advanced Colorectal Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2013-01-23
Start Date:
2000-03-31
Completion:
2003-03-31
Conditions
  • Adenocarcinoma of the Colon
  • Adenocarcinoma of the Rectum
  • Recurrent Colon Cancer
  • Recurrent Rectal Cancer
  • Stage III Colon Cancer
  • Stage III Rectal Cancer
  • Stage IV Colon Cancer
  • Stage IV Rectal Cancer
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT00005064 | COMPLETED | PHASE1
30 participants

PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome

Study Type:
INTERVENTIONAL
Last Updated:
2013-01-23
Start Date:
2000-02-29
Completion:
2002-10-31
Conditions
  • Adult Acute Promyelocytic Leukemia (M3)
  • Blastic Phase Chronic Myelogenous Leukemia
  • Previously Treated Myelodysplastic Syndromes
  • Recurrent Adult Acute Lymphoblastic Leukemia
  • Recurrent Adult Acute Myeloid Leukemia
  • Refractory Anemia With Excess Blasts
  • Refractory Anemia With Excess Blasts in Transformation
  • Relapsing Chronic Myelogenous Leukemia
Interventions
  • DRUG
No Results Yet
NCT00003167 | COMPLETED | PHASE1
24 participants

Gene Therapy in Treating Patients With Advanced Bladder Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2013-01-23
Start Date:
1998-05-31
Completion:
2002-12-31
Conditions
  • Recurrent Bladder Cancer
  • Stage I Bladder Cancer
  • Stage II Bladder Cancer
  • Stage III Bladder Cancer
  • Stage IV Bladder Cancer
  • Transitional Cell Carcinoma of the Bladder
Interventions
  • BIOLOGICAL
No Results Yet
NCT01772927 | UNKNOWN
30 participants

Clinical Tolerance of Numeta 13%

Study Type:
OBSERVATIONAL
Last Updated:
2013-01-21
Start Date:
2013-01-31
Completion:
2013-05-31
Conditions
  • Other Preterm Infants
  • Transitory Neonatal Electrolyte Disturbance
  • Disorder of Mineral Metabolism
  • Failure to Thrive
Interventions
  • DIETARY_SUPPLEMENT
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page